Core Medical Publishing
Home About Us Products & Services
Frequently Asked Questions Contact Us Privacy Policy
Publishing
Core Evidence
Editorial
Aims and Scope
Features and Benefits
Online Early
Current Issue
Previous Issues
Future Issues
Free Trial
Subscribe
Permissions and Reprints
Editorial Information
Call For Papers
Continuing Medical Education
New CME Activities
MedicVision
MedicVision
Online Early
Online Early
Current Issue
Current Issue
Core Evidence
Vol. 2, No. 4
July, 2008
ISSN: 1555-1741
Free Trial
Free Trial
Sample Sample
Previous Issues

Vol 1 (1), 2005 (ISSN: 1555-1741)

Contents
Dasatinib: the emerging evidence of its potential in the treatment
of chronic myeloid leukemia
Aliskiren in hypertension: evidence for its potential therapeutic value
Roflumilast: the evidence for its clinical potiential in the treatment
of chronic obstructive pulmonary disease
Pramipexole in restless legs syndrome: an evidence-based review
of its effectiveness on clinical outcomes
Sevelamer as a phosphate binder in adult hemodialysis patients:
an evidence-based review of its therapeutic value
Fosphenytoin for the treatment of status epilepticus: an evidence-based assessment of its clinical and economic outcomes
To purchase a full text article, go to www.ingentaconnect.com or www.thepharmyard.com

 

Vol 1 (2), 2005 (ISSN: 1555-1741)

Contents
Lapatinib: the evidence for its therapeutic value in metastatic
breast cancer
Exubera® (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetes
Topiramate: the evidence for its therapeutic value in the prevention
of migraine
Eplerenone: the evidence for its place in the treatment of heart failure after myocardial infarction
Dutasteride: an evidence-based review of its clinical impact in
the treatment of benign prostatic hyperplasia
To purchase a full text article, go to www.ingentaconnect.com or www.thepharmyard.com

Vol 1 (3), 2006 (ISSN: 1555-1741)

Contents
FTY720 in multiple sclerosis: the emerging evidence of its
therapeutic value
K-111: the emerging evidence for its potential in the treatment of the metabolic syndrome
Tigecycline: an evidence-based review of its antibacterial activity
and effectiveness in complicated skin and soft tissue and intraabdominal infections
Donepezil in Alzheimer’s disease: an evidence-based review of its impact on clinical and economic outcomes
To purchase a full text article, go to www.ingentaconnect.com or www.thepharmyard.com

Vol 1 (4), 2006 (ISSN: 1555-1741)

Contents
Eltrombopag: the emerging evidence of its therapeutic value
in thrombocytopenia
Ciclesonide in persistent asthma: the evidence of its
therapeutic value
Aripiprazole: the evidence of its therapeutic impact in schizophrenia
Bortezomib: the evidence of its clinical impact in multiple myeloma
To purchase a full text article, go to www.ingentaconnect.com or www.thepharmyard.com

Vol 2 (1), 2007 (ISSN: 1555-1741)

Contents
Maraviroc: the evidence for its potential in the management of HIV
Aprepitant: the evidence for its place in the prevention of chemotherapy-induced nausea and vomiting
Bevacizumab: the evidence for its clinical potential in the treatment
of nonsmall cell lung cancer
Etanercept in psoriasis: the evidence of its therapeutic impact
Perindopril: the evidence of its therapeutic impact in hypertension
To purchase a full text article, go to www.ingentaconnect.com or www.thepharmyard.com

Vol 2 (2), 2007 (ISSN: 1555-175X)

Contents
Panitumumab: the evidence of its therapeutic potential in metastatic colorectal cancer care
Insulin glargine in the management of diabetes mellitus: an
evidence-based assessment of its clinical efficacy and
economic value
Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas
Rituximab maintenance in relapsed or refractory follicular
non-Hodgkins lymphoma: the evidence of its therapeutic value
Lumiracoxib: the evidence of its clinical impact on the treatment
of osteoarthritis
To purchase a full text article, go to www.ingentaconnect.com or www.thepharmyard.com

Vol. 2, No. 3 February, 2008

Contents
Infliximab: the evidence for its place in therapy in ulcerative colitis
Abatacept: the evidence for its place in the treatment
of rheumatoid arthritis
Rimonabant: the evidence for its use in the treatment of obesity
and the metabolic syndrome
Pioglitazone and metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy
Eritoran: the evidence of its therapeutic potential in sepsis
Certolizumab pegol: an evidence-based review of its place in the treatment of Crohn’s disease
To purchase a full text article, go to www.ingentaconnect.com or www.thepharmyard.com

Alternatively, to subscribe to Core Evidence, please click here

 
HOME  |  ABOUT US   |  PRODUCTS & SERVICES  |  FAQ  |  CONTACT US  |  PRIVACY POLICY
| Terms and conditions